negative study: A Phase I Study of Unimolecular Pentavalent Immunization of Patients with Epithelial Ovarian, FT, or PP in 1st Remission Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Tuesday, September 06, 2016

negative study: A Phase I Study of Unimolecular Pentavalent Immunization of Patients with Epithelial Ovarian, FT, or PP in 1st Remission



A Phase I Study of Unimolecular Pentavalent (Globo-H-GM2-sTn-TF-Tn) Immunization of Patients with Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remission

 With a median follow-up of 19 months (range, 2–39), 20 patients (83%) recurred and six (25%) died.

0 comments :

Post a Comment

Your comments?